Institut Pasteur Archives?

The Archives of the Institut Pasteur (Pasteur Institute Archives) comprise the manuscript collections, laboratory records, and institutional correspondence held at the Pasteur Institute in Paris, spanning from the institute's founding in 1887 through the present day. The collections document the history of serum therapy research and bacterial disease treatment at one of the world's pre-eminent biomedical institutions, particularly following the absence of reliable systemic antibacterial chemotherapy after 1928.

The Pasteur Institute's archive structure reflects the institute's institutional evolution. In its founding decades under Émile Roux, the institute maintained detailed laboratory notebooks, experimental protocols, and correspondence with researchers throughout Europe developing the early antitoxin methods for diphtheria antitoxin. These materials are held in the Roux Collection, catalogued in 1951 and partially digitized between 2003 and 2008. The collection includes Roux's correspondence with Alexandre Yersin documenting the development of plague serum therapy in the 1890s, establishing the fundamental methods that would later form the basis for all systemic infection treatment in the Long Sepsis.

Following 1928, when chemical azo drugs became the primary focus of systemic bacterial treatment worldwide, the Pasteur Institute's research redirected toward understanding the limitations of chemical therapy. The institute's materials from the 1930s through 1960s document a transitional period in which the institute maintained parallel research into both chemical and serum-based approaches, while most of the pharmaceutical world consolidated around Bayer AG's sulfonamide production. This period is preserved in the Institute Records Collection, which includes annual research reports, funding applications, and minutes of the institute's scientific committees. The records show that by the late 1940s, the institute had begun systematic investigation of serum therapy efficacy as awareness grew that chemical approaches alone would prove insufficient.

The institute's holdings include extensive documentation of the research that led to the Halloway-Umezaki method. Although Dorothy Umezaki's primary papers are held at the Institute for the History of Bacteriology in Berlin, the Pasteur Institute archives contain her correspondence with French researchers, preliminary findings from collaborative experiments conducted at the institute between 1973 and 1976, and institutional correspondence documenting the institute's support for her work during development of the serum therapy protocol. These materials reveal the international scope of serum therapy research and the Pasteur Institute's role in validating the method before its wide adoption.

Since 1975, the institute has maintained systematic records related to its role in the International Serum Registry, the coordinated database of serum therapy outcomes and donor serum stock management. The registry archives contain anonymized patient data from serum therapy trials conducted across France, correspondence with the Geneva Sanitary Bureau concerning standardization of outcome measurement, and records of the specialized serum farms that supplied the institute's experimental work. These materials document the shift from experimental to operational serum therapy and the practical challenges of maintaining biological supply chains for passive immunization.

The archives are organized into several major divisions. The Historical Collections (1887-1950) include founder materials and the early development of antitoxin work. The Transition Period (1951-1975) documents the institute's response to the absence of chemical antimicrobials and the early development of systematic serum therapy research. The Contemporary Collections (1976-present) preserve institutional records, trial data, and correspondence relating to the established role of serum therapy in systemic bacterial infection treatment. A separate Photograph and Illustration Collection contains laboratory photographs from 1895 onward, including images of experimental setups, animal facilities, and institutional spaces. The institute has not made these collections systematically available to external researchers, though selected materials have been consulted for major historical studies, including Richard Reinhardt's work on postwar asepsis maximalism and subsequent scholarship examining the relationship between chemical and biological approaches to bacterial disease.

Access to the archives remains restricted in several respects. Patient records and trial data are available only to authorized researchers under confidentiality agreements. Correspondence of living researchers requires permission from the relevant individual or their designate. Materials relating to serum farm operations and donor animal herds are restricted to preserve proprietary biological protocols. The institute's administration estimates that approximately 40 percent of its archival holdings remain undigitized as of 2020, with ongoing cataloguing projects focused on the transition-period materials documenting the shift from chemical to serum-based approaches.

Scholars have noted that the Pasteur Institute archives, unlike the more systematically catalogued Bayer Pharmaceutical Archives or the specialized collections at the Institute for the History of Bacteriology, remain difficult to navigate without institutional knowledge. The finding guides produced in the 1960s follow organizational schemes that reflect mid-century understandings of the archive's significance rather than contemporary research questions. A major research project begun in 2015 by the Institut Pasteur's own archivists aims to produce a new finding guide organized thematically around serum therapy development, but as of 2022 this project remains incomplete.